Majority control over cognitive health platform Happyneuron has been taken by Raise Impact in a recent acquisition deal
In a groundbreaking move, Raise Impact, an impact investment fund, has acquired a majority stake in Happyneuron, a leading digital platform specializing in cognitive health assessment and rehabilitation. This investment marks a significant step forward in the mission to improve patient care, particularly for children with learning disorders such as dyslexia, dyspraxia, and dysphasia, in France.
Happyneuron's platform has made a substantial impact in France, where diagnosis for many cognitive disorders can be slow due to high demand and limited availability. By providing digital tools that are science-based and developed by medical health professionals, Happyneuron helps practitioners conduct precise, efficient assessments and design tailored care plans. This accelerated diagnostic process reduces delays that previously hindered early intervention, thereby greatly influencing educational outcomes and overall cognitive development.
The platform offers 40 modules targeting key cognitive functions such as language, hearing, neurological impairments, and mathematical cognition. This comprehensive approach supports practitioners in identifying learning disorders accurately and expedites the diagnostic process, thereby reducing waiting times that previously extended up to a year.
Raise Impact targets mission-driven companies that address challenges related to energy transition, agricultural transition, circular economy, and social inclusion. The investment in Happyneuron aligns with this mission, as the platform's solutions are designed by professionals based on their respective fields, helping practitioners to accurately interpret results and design the right care plan.
The investment will also be used to explore new fields of therapy, including through external growth. Raise Group will help Happyneuron to develop a structured approach to measuring and managing its impact on improving patient care.
Happyneuron's platform is used for the treatment of cognitive and language disorders and has been adopted by hospitals and other healthcare professionals, including neuropsychologists and clinical psychologists. The company generates 70% of its revenue from subscriptions to its platform, demonstrating a resilient business model with stable user retention for significant reinvestment into research and development.
More than 10,000 speech therapists have subscribed as users to Happyneuron's platform. The platform has been launched in Luxembourg, Belgium, Switzerland, and North America and aims to continue its expansion in these markets. The investment by Raise Impact will be used to grow Happyneuron's client base of healthcare practitioners, furthering its mission to revolutionize cognitive health assessment and rehabilitation.
The fund's investment amount for Happyneuron is undisclosed. However, it is worth noting that Raise Impact focuses on taking active minority and majority controlling shares in European small and mid-cap growth companies, with ticket sizes ranging from €10m to €30m.
In summary, Happyneuron is a key digital health innovation in France that improves cognitive disorder diagnosis speed and rehabilitation quality, particularly benefiting children with learning disabilities by providing timely, evidence-based cognitive health solutions. The investment by Raise Impact will further propel Happyneuron towards its goal of expanding its reach and impact in the field of cognitive health.
- Raise Impact's investment in Happyneuron, a digital platform specializing in cognitive health assessment and rehabilitation, aligns with their focus on development finance in areas like energy transition and social impact.
- By leveraging digital tools and science-based methods, Happyneuron accelerates the diagnostic process for cognitive disorders, thereby influencing educational outcomes and overall cognitive development.
- The investment will also support Happyneuron in exploring new therapies and treatments, aiming to expand its impact beyond France.
- With their expertise in private equity and real-estate, Raise Group will help Happyneuron develop a structured approach to measuring and managing its social impact.
- Happyneuron's platform, generating 70% of its revenue from subscriptions, demonstrates a resilient business model with stable user retention, providing resources for research and development.
- The fund's investment in Happyneuron will not only help grow its client base but also contribute to revolutionizing cognitive health assessment and rehabilitation services, particularly for children with learning disorders.
